In these tumors, MYC is deregulated due to aberrant transcriptional activation, gene amplification, or mRNA/protein stabilization correlated with a loss of BRCA or TP53 tumor suppressors, which normally inhibit MYC’s transcriptional and transforming activities. The gene discussed is MYC; the disease is neoplasm.